Accessibility Menu
908 Devices Stock Quote

908 Devices (NASDAQ: MASS)

$8.49
(1.1%)
+0.09
Price as of October 24, 2025, 3:57 p.m. ET

KEY DATA POINTS

Current Price
$8.51
Daily Change
(1.1%) +$0.09
Day's Range
$8.44 - $8.76
Previous Close
$8.51
Open
$8.53
Beta
1.79
Volume
171,245
Average Volume
338,281
Market Cap
307.1M
Market Cap / Employee
$8.51M
52wk Range
$1.81 - $9.34
Revenue
-
Gross Margin
0.45%
Dividend Yield
N/A
EPS
-$2.14
CAPs Rating
-
Industry
Electronic Equipment, Instruments and Components

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

908 Devices Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MASS+157.1%N/AN/A-83%
S&P+16.9%+95.99%+14.39%+83%

908 Devices Company Info

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$13.04M-7.2%
Gross Profit$6.04M-16.8%
Gross Margin46.30%-5.3%
Market Cap$255.69M44.0%
Market Cap / Employee$1.04M0.0%
Employees2467.0%
Net Income-$12.91M-2.9%
EBITDA$0.70M-73.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$61.75M31.9%
Accounts Receivable$6.21M-43.5%
Inventory15.5-16.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$4.00M16.3%
Short Term Debt$0.43M-79.9%

Ratios

Q2 2025YOY Change
Return On Assets-35.70%-17.6%
Return On Invested Capital-23.12%-3.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$5.91M52.3%
Operating Free Cash Flow-$5.78M55.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.920.581.371.6047.90%
Price to Sales2.181.282.584.2327.19%
Price to Tangible Book Value1.621.032.272.1072.36%
Enterprise Value to EBITDA-5.35-1.36-5.31201.50411.98%
Return on Equity-40.0%-51.6%-45.0%-46.8%104.00%
Total Debt$7.18M$6.61M$3.77M$4.43M-20.76%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.